TOKYO, June 1 (Reuters) - Takeda Pharmaceutical Co. Ltd., Japan’s biggest drug maker, has dropped development of a medicine that combined its diabetes drug Actos and a drug candidate that controls high blood pressure.
TOKYO, June 1 (Reuters) - Takeda Pharmaceutical Co. Ltd., Japan’s biggest drug maker, has dropped development of a medicine that combined its diabetes drug Actos and a drug candidate that controls high blood pressure.
